Cite

HARVARD Citation

    Oliver, M. et al. (2022). Determinants of Tumor Necrosis Factor Inhibitor Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes. ACR open rheumatology. 4 (1), pp. 19-26. [Online]. 
  
Back to record